May 1, 2012 — The fluoroquinolone antibiotic levofloxacin (Levaquin, Janssen Pharmaceuticals Inc) has been approved as part of a US Food and Drug Administration (FDA) priority review application for ...
This study tested whether levofloxacin, at a new high dose of 750 mg, was effective for the treatment of complicated skin and skin-structure infections (SSSIs). Patients with complicated SSSIs (n = ...
7-day levofloxacin/dexamethasone eye drops as effective as standard treatment after cataract surgery
Santen EMEA and NTC are delighted to announce that the results of their phase III clinical study, LEADER7, have been published in Eye. The study demonstrated for the ...
WASHINGTON, Oct. 27 Ortho-McNeil presented interim results from a retrospective analysis examining medical resource utilization during hospitalization of adult patients for community-acquired ...
Two landmark clinical trials involving researchers at University College London (UCL) have demonstrated that levofloxacin is the first effective treatment to prevent multidrug-resistant tuberculosis ...
Background: The current Canadian and US guidelines for the treatment of multidrug-resistant latent tuberculosis infection advocate the use of pyrazinamide and a fluoroquinolone as a first-line ...
A 3-month course of levofloxacin does not prevent BK viruria after kidney transplantation but does increase the risk of adverse events, according to data from a new study. “Quinolone prophylaxis was ...
Federal drug regulators are considering approving Johnson & Johnson’s powerful antibiotic Levaquin as a treatment for pneumonic plague, the ancient and deadly disease still feared for its potential ...
Currently there is no standard uniformly accepted treatment of giving antibiotic prophylaxis to children and adults with acute lymphoblastic leukemia (ALL) because there have been no clinical data or ...
To the Editor: Davidson et al. (March 7 issue) 1 describe four patients with pneumococcal pneumonia in whom therapy with oral levofloxacin failed. We report on a patient with pneumococcal pneumonia ...
A recent report published in the Journal of Pharmacy Practice describes the case of a 75-year-old female patient who developed acquired hemophilia following levofloxacin administration and then ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback